MAPK1 and chronic myelogenous leukemia, BCR-ABL1 positive: In an attempt to extrapolate our cell culture observation to human primary material, we also analyzed the activation status of Erk2 in few samples from IM resistant CML patients -with no mutation in BCR/ABL- and IM responders.